fda bpc-157 warning letter 2024 Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review FDA warning letter - IPQ
Description
The results of treatment for pernicious anemia are generally permanent as long as the person continues to follow the treatment plan, including regular vitamin B12 replacement therapy and maintaining a diet rich in vitamin B12

In eukaryotic cells, actin exists in two forms: G-actin (Globular/Treine Actin): Free monomeric actin F-actin (Filamentous Actin): Polymerized actin filaments TB-500 binds to G-actin in a 1:1 stoichiometry, effectively maintaining a pool of monomeric actin available for rapid polymerization when needed

I cannot say for certain what percentage was the peptide versus just healing naturally, but the timeline beat every estimate I was given

Acknowledgments The authors acknowledge the funding of the National Natural Science Foundation of China [No.82173989] and the support from the National Administration of Traditional Chinese Medicine [No.zyyzdxk-2023272]
